Magle Chemoswed Holding AB
STO:MAGLE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Magle Chemoswed Holding AB
Other Liabilities
Magle Chemoswed Holding AB
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Magle Chemoswed Holding AB
STO:MAGLE
|
Other Liabilities
kr657k
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AddLife AB
STO:ALIF B
|
Other Liabilities
kr442m
|
CAGR 3-Years
30%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
BICO Group AB
STO:BICO
|
Other Liabilities
kr29.7m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
Biotage AB
STO:BIOT
|
Other Liabilities
kr11m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
6%
|
|
|
G
|
Genovis AB
STO:GENO
|
Other Liabilities
kr72.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
66%
|
CAGR 10-Years
N/A
|
|
|
MedCap AB (publ)
STO:MCAP
|
Other Liabilities
kr159m
|
CAGR 3-Years
205%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Magle Chemoswed Holding AB
Glance View
Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.
See Also
What is Magle Chemoswed Holding AB's Other Liabilities?
Other Liabilities
657k
SEK
Based on the financial report for Dec 31, 2025, Magle Chemoswed Holding AB's Other Liabilities amounts to 657k SEK.
What is Magle Chemoswed Holding AB's Other Liabilities growth rate?
Other Liabilities CAGR 3Y
-61%
Over the last year, the Other Liabilities growth was 4%. The average annual Other Liabilities growth rates for Magle Chemoswed Holding AB have been -61% over the past three years .
